The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects - Letter to the editor Journal Article

  

Authors:	Seandel, M.; Shia, J.; Linkov, I.; Maki, R. G.; Antonescu, C. R.; Dupont, J.
Article Title:	The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects - Letter to the editor
Keywords:	immunohistochemistry; adult; treatment outcome; middle aged; human cell; drug activity; histopathology; anamnesis; case report; sunitinib; antineoplastic agents; follow up; letter; cell division; gastrointestinal stromal tumor; imatinib; gastrointestinal stromal tumors; tumor biopsy; tumor regression; drug effect; neoplasm, residual; enzyme inhibitors; tumor growth; indoles; pyrroles; angiogenesis inhibitors; antiangiogenic activity; phosphotransferases
Journal Title:	Clinical Cancer Research
Volume:	12
Issue:	20
ISSN:	1078-0432
Publisher:	American Association for Cancer Research
Date Published:	2006-10-15
Start Page:	6203
End Page:	6204
Language:	English
DOI:	10.1158/1078-0432.ccr-06-1292
PUBMED:	17062698
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-33750611016&partnerID=40&md5=be7f1919a27d432fdbbeb7c354b5e246
Notes:	--- - "Cited By (since 1996): 14" - "Export Date: 4 June 2012" - "CODEN: CCREF" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/28041